Zhu S N, Nölle B, Duncker G
University Eye Hospital, Kiel, Germany.
Br J Ophthalmol. 1997 Jan;81(1):80-4. doi: 10.1136/bjo.81.1.80.
This study was undertaken to confirm the distribution and expression of the molecule CD44 on human corneas under normal and pathological conditions.
Fifty eight corneal buttons from adult patients suffering from various corneal diseases and four normal corneas were included in this study. Frozen sections were stained immunohistochemically with monoclonal antibodies against human CD44 using an APAAP method and observed under a light microscope.
In normal corneas CD44 was predominantly expressed on the membranes of basal epithelial cells and on the keratocytes, as well as on the vascular endothelial cells of the corneal limbi, but was not expressed on corneal endothelial cells. Enhanced expression of CD44 was observed on the epithelium of corneas with inflammation and allograft rejection. In a number of abnormal conditions including allograft rejection, corneal trauma, primary and secondary corneal endothelial decompensation the remaining endothelial cells stained positively for CD44. However, in some corneas of keratitis, keratoconus, and dystrophy the endothelium which appeared relatively integral in morphology and amount remained CD44 negative.
These results suggest that CD44, the hyaluronate receptor, may play an important role in corneal cell-cell and cell-matrix interactions. Its regulation is closely related to corneal inflammatory reactions. The induction of CD44 on corneal endothelium might play a potential role in compensatory processes when corneal endothelial cells are injured.
本研究旨在确定分子CD44在正常和病理条件下人类角膜中的分布及表达情况。
本研究纳入了58个来自患有各种角膜疾病的成年患者的角膜组织块以及4个正常角膜。采用抗人CD44单克隆抗体,通过碱性磷酸酶抗碱性磷酸酶(APAAP)法对冰冻切片进行免疫组织化学染色,并在光学显微镜下观察。
在正常角膜中,CD44主要表达于基底上皮细胞、角膜基质细胞的细胞膜上,以及角膜缘的血管内皮细胞上,但在角膜内皮细胞上不表达。在有炎症和移植排斥反应的角膜上皮中观察到CD44表达增强。在包括移植排斥反应、角膜创伤、原发性和继发性角膜内皮失代偿等多种异常情况下,剩余的内皮细胞CD44染色呈阳性。然而,在一些角膜炎、圆锥角膜和角膜营养不良的角膜中,形态和数量相对完整的内皮细胞CD44仍为阴性。
这些结果表明,透明质酸受体CD44可能在角膜细胞 - 细胞和细胞 - 基质相互作用中起重要作用。其调节与角膜炎症反应密切相关。角膜内皮细胞上CD44的诱导可能在角膜内皮细胞受损时的代偿过程中发挥潜在作用。